• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific’s next-gen wireless heart implant monitoring keeps patients out of the office

Boston Scientific’s next-gen wireless heart implant monitoring keeps patients out of the office

June 14, 2012 By MassDevice staff

Boston Scientific press release

Boston Scientific (NYSE:BSX) unveiled its next-generation Latitude NXT patient monitoring system in Europe this week, implanting the 1st patient with an Ingenio pacemaker designed to connect with a home-based wireless communicator that can tie in data from blood pressure readings as well as a weight scale.

"The system offers clinicians the most comprehensive suite of diagnostic tools in the CRM industry to support proactive treatment decisions and provide an opportunity to verify improvement of clinical outcomes," Dr. Roberto Verlato, who implanted the device at Camposampiero Hospital in Verona, Italy, said in prepared remarks.

The Latitude NXT system works with the Natick, Mass.-based device giant’s Ingenio and Advantio pacemakers and its Invive cardiac resynchronization therapy pacemakers, according to a press release.

The remote monitoring system includes an at-home wireless communicator that initiates data transfer with the pacemaker and sends information to physicians via text or email alerts, maintains the data on a website and can integrate with hospital medical record databases.

Boston Scientific hopes the new system can take the place of some office visits as well as save time healthcare workers would spend manually entering patient heart data into health records. Automated data transfer into patient records could save 15 minutes per patient per transmission, according to the company.

By combining heart data with blood pressure and weight measurements, the company aims to provide physicians with more tools for defining patient risk categories and making proactive treatment decisions, according to the release.

The Latitude NXT system is currently under FDA review, but it not yet available in the U.S.

Filed Under: Health Information Technology, News Well Tagged With: Boston Scientific, Cardiac Rhythm Management, Remote Patient Monitoring

More recent news

  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe
  • Aortyx raises $16M for bioresorbable aortic patch

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy